Characterisation of the histone acetyltransferase KAT7 as a novel target for radiosensitisation
<p>Radiotherapy is one of the pillars of modern cancer therapy. However, side effects associated with normal tissue toxicity limit the effectiveness of this treatment. It is therefore desirable to develop tumour-specific radiosensitising agents, which can increase tumour cell kill without incr...
第一著者: | Bittner, M |
---|---|
その他の著者: | Higgins, G |
フォーマット: | 学位論文 |
出版事項: |
2017
|
類似資料
-
Histone Deacetylases and Their Potential as Targets to Enhance Tumour Radiosensitisation
著者:: Jennifer Antrobus, 等
出版事項: (2022-03-01) -
The NLRP11 Protein Bridges the Histone Lysine Acetyltransferase KAT7 to Acetylate Vimentin in the Early Stage of Lung Adenocarcinoma
著者:: Rui Yang, 等
出版事項: (2023-09-01) -
Myst2/Kat7 histone acetyltransferase interaction proteomics reveals tumour-suppressor Niam as a novel binding partner in embryonic stem cells
著者:: Mercedes Pardo, 等
出版事項: (2017-08-01) -
The histone deacetylase inhibitor panobinostat as a radiosensitiser in bladder cancer
著者:: Groselj, B
出版事項: (2014) -
Histone deacetylase inhibitors as radiosensitisers: Effects on DNA damage signalling and repair
著者:: Groselj, B, 等
出版事項: (2013)